T. Van Der Cammen - Academia.edu (original) (raw)
Uploads
Papers by T. Van Der Cammen
The journal of nutrition, health & aging, 2009
As Europe faces an ageing population with increasing pressure on long term care, it is important ... more As Europe faces an ageing population with increasing pressure on long term care, it is important for different systems to be compared and contrasted for the benefit of all. We compare long term care in the Netherlands to England, by examining the different care models, in terms of patient outcomes, quality of care, continuity of care and funding.
The Journal of Nutrition, Health and Aging, 2009
Orthostatic hypotension (OH) is a frequent phenomenon in older persons and usually has a multifac... more Orthostatic hypotension (OH) is a frequent phenomenon in older persons and usually has a multifactorial origin. When the diagnosis is suspected, the work-up should initially be directed at the most prevalent causes. This clinical algorithm may be a useful tool in the diagnostic process.
Journal of Epidemiology & Community Health, 2012
Background The rapid increase of frail older people worldwide will have a substantial impact on h... more Background The rapid increase of frail older people worldwide will have a substantial impact on healthcare systems. The frailty process may be delayed or even reversed, which makes it attractive for early interventions. However, little is known about the determinants of frailty state changes. The aim of this study is to compare socio-demographic determinants of worsening in frailty state in 11 European countries. Methods Data of 14 424 community-dwelling persons aged 55years,enrolledin2004intheSurveyofHealth,AgeingandRetirementinEurope,wereanalysed.Threefrailtystateswereidentified(non−frail,pre−frailandfrail)usingFried′scriteria,andfrailtystatechangesovera2−yearperiodweredetermined.Multinomialregressionanalysesadjustedforbaselinefrailtystatewereconductedtoinvestigatewhethersex,age,maritalstatusandlevelofeducationdeterminedaworseninginfrailtystateinthetotalandcountry−specificEuropeanpopulation.ResultsOfallindividuals,22.155 years, enrolled in 2004 in the Survey of Health, Ageing and Retirement in Europe, were analysed. Three frailty states were identified (non-frail, pre-frail and frail) using Fried's criteria, and frailty state changes over a 2-year period were determined. Multinomial regression analyses adjusted for baseline frailty state were conducted to investigate whether sex, age, marital status and level of education determined a worsening in frailty state in the total and country-specific European population. Results Of all individuals, 22.1% worsened, 61.8% showed no change and 16.1% improved in frailty state. Women, those aged 55years,enrolledin2004intheSurveyofHealth,AgeingandRetirementinEurope,wereanalysed.Threefrailtystateswereidentified(non−frail,pre−frailandfrail)usingFried′scriteria,andfrailtystatechangesovera2−yearperiodweredetermined.Multinomialregressionanalysesadjustedforbaselinefrailtystatewereconductedtoinvestigatewhethersex,age,maritalstatusandlevelofeducationdeterminedaworseninginfrailtystateinthetotalandcountry−specificEuropeanpopulation.ResultsOfallindividuals,22.165 years, and lower educated persons showed an increased risk of worsening in frailty state. In Southern European countries, there was an earlier and larger increase in risk of worsening in frailty state in life, which was more pronounced in women compared with men. Conclusions In Europe, persons aged $65 years, women and lower educated persons are at increased risk of worsening in frailty state. Differences between countries indicate that interventions aimed at delaying the frailty process in Southern European countries should start earlier with more attention towards women. < Additional appendices are published online only. To view these files please visit the journal online (http://dx.
The journal of nutrition, health & aging, 2009
Placebo-controlled trials have shown that rivastigmine can delay cognitive deterioration in patie... more Placebo-controlled trials have shown that rivastigmine can delay cognitive deterioration in patients with mild to moderate Alzheimer's disease (AD). Benefits on cognitive functioning, as measured with the ADAS-Cog, occur on a daily dose of 6-12 mg when used for at least 6 months. The effect of rivastigmine on the adequacy of spontaneous speech is unknown. This study aimed to (i) compare the spontaneous speech of AD patients with the spontaneous speech of persons with normal cognition, (ii) compare the spontaneous speech of the same group of AD patients before and after treatment with rivastigmine. Spontaneous speech of AD patients (n=9) was compared with that of healthy elderly volunteers (n=8). In the patient group, spontaneous speech was analysed before and after treatment with rivastigmine. Before treatment, 100% discrimination was found between the spontaneous speech of AD patients and of healthy volunteers based on two linguistic parameters: empty words and compound sentenc...
The journal of nutrition, health & aging, 2009
As Europe faces an ageing population with increasing pressure on long term care, it is important ... more As Europe faces an ageing population with increasing pressure on long term care, it is important for different systems to be compared and contrasted for the benefit of all. We compare long term care in the Netherlands to England, by examining the different care models, in terms of patient outcomes, quality of care, continuity of care and funding.
The Journal of Nutrition, Health and Aging, 2009
Orthostatic hypotension (OH) is a frequent phenomenon in older persons and usually has a multifac... more Orthostatic hypotension (OH) is a frequent phenomenon in older persons and usually has a multifactorial origin. When the diagnosis is suspected, the work-up should initially be directed at the most prevalent causes. This clinical algorithm may be a useful tool in the diagnostic process.
Journal of Epidemiology & Community Health, 2012
Background The rapid increase of frail older people worldwide will have a substantial impact on h... more Background The rapid increase of frail older people worldwide will have a substantial impact on healthcare systems. The frailty process may be delayed or even reversed, which makes it attractive for early interventions. However, little is known about the determinants of frailty state changes. The aim of this study is to compare socio-demographic determinants of worsening in frailty state in 11 European countries. Methods Data of 14 424 community-dwelling persons aged 55years,enrolledin2004intheSurveyofHealth,AgeingandRetirementinEurope,wereanalysed.Threefrailtystateswereidentified(non−frail,pre−frailandfrail)usingFried′scriteria,andfrailtystatechangesovera2−yearperiodweredetermined.Multinomialregressionanalysesadjustedforbaselinefrailtystatewereconductedtoinvestigatewhethersex,age,maritalstatusandlevelofeducationdeterminedaworseninginfrailtystateinthetotalandcountry−specificEuropeanpopulation.ResultsOfallindividuals,22.155 years, enrolled in 2004 in the Survey of Health, Ageing and Retirement in Europe, were analysed. Three frailty states were identified (non-frail, pre-frail and frail) using Fried's criteria, and frailty state changes over a 2-year period were determined. Multinomial regression analyses adjusted for baseline frailty state were conducted to investigate whether sex, age, marital status and level of education determined a worsening in frailty state in the total and country-specific European population. Results Of all individuals, 22.1% worsened, 61.8% showed no change and 16.1% improved in frailty state. Women, those aged 55years,enrolledin2004intheSurveyofHealth,AgeingandRetirementinEurope,wereanalysed.Threefrailtystateswereidentified(non−frail,pre−frailandfrail)usingFried′scriteria,andfrailtystatechangesovera2−yearperiodweredetermined.Multinomialregressionanalysesadjustedforbaselinefrailtystatewereconductedtoinvestigatewhethersex,age,maritalstatusandlevelofeducationdeterminedaworseninginfrailtystateinthetotalandcountry−specificEuropeanpopulation.ResultsOfallindividuals,22.165 years, and lower educated persons showed an increased risk of worsening in frailty state. In Southern European countries, there was an earlier and larger increase in risk of worsening in frailty state in life, which was more pronounced in women compared with men. Conclusions In Europe, persons aged $65 years, women and lower educated persons are at increased risk of worsening in frailty state. Differences between countries indicate that interventions aimed at delaying the frailty process in Southern European countries should start earlier with more attention towards women. < Additional appendices are published online only. To view these files please visit the journal online (http://dx.
The journal of nutrition, health & aging, 2009
Placebo-controlled trials have shown that rivastigmine can delay cognitive deterioration in patie... more Placebo-controlled trials have shown that rivastigmine can delay cognitive deterioration in patients with mild to moderate Alzheimer's disease (AD). Benefits on cognitive functioning, as measured with the ADAS-Cog, occur on a daily dose of 6-12 mg when used for at least 6 months. The effect of rivastigmine on the adequacy of spontaneous speech is unknown. This study aimed to (i) compare the spontaneous speech of AD patients with the spontaneous speech of persons with normal cognition, (ii) compare the spontaneous speech of the same group of AD patients before and after treatment with rivastigmine. Spontaneous speech of AD patients (n=9) was compared with that of healthy elderly volunteers (n=8). In the patient group, spontaneous speech was analysed before and after treatment with rivastigmine. Before treatment, 100% discrimination was found between the spontaneous speech of AD patients and of healthy volunteers based on two linguistic parameters: empty words and compound sentenc...